openPR Logo
Press release

Acute Pancreatitis Market expected to reach USD 7372.01 Million By 2025 at CAGR of 5.91%

01-13-2022 01:12 PM CET | Health & Medicine

Press release from: Market Research Future (MRFR)

Acute Pancreatitis Market expected to reach USD 7372.01 Million

Acute Pancreatitis Market is estimated to be valued at USD 7372.01 Million by 2025 and is expected to register a CAGR of 5.91% during the forecast period. There are several other reasons, such as heavy alcohol consumption, ingested medicines, and others that cause acute pancreatitis. The rising prevalence of gallstones and high consumption of alcohol is driving the global acute pancreatitis market. However, stringent regulations imposed by the FDA (Food and Drug Administration) are expected to hamper the growth of this market.

Acute pancreatitis is a condition where the pancreas becomes inflamed. The most common cause of acute pancreatitis is stones in the gallbladder. Acute pancreatitis is the single-most frequent gastrointestinal cause for hospital admissions in the US, with nearly 275,000 hospitalizations annually.

Market Players

Market Research Future (MRFR) recognizes CalciMedica, SCM Lifescience, Samsung Bioepis, GNT Pharma Co., Baxter International Inc., B. Braun Melsungen AG, General Electric Company, Medtronic, Boston Scientific Corporation, and Fresenius Kabi USA as the key players in the Global Acute Pancreatitis Market.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/1565

Segment Analysis

The Global Acute Pancreatitis Market has been segmented into Cause, Treatment & Diagnosis, and End User.

Based on the cause, the global acute pancreatitis market has been segmented into gallstones, alcohol, and others. The gallstones segment accounted for the largest market share of 49.52% in 2018 and is expected to exhibit a CAGR of 5.88% by the end of the forecast period.  Rising cases of gall stones worldwide and growing older population along with hereditary predispositions are major risk factors causing gall stones, which is driving the growth of the acute pancreatitis market. For instance, according to the World Gastroenterology Organization, about 20 million people in the USA (15% of the population) had gallstones in 2016.

On the basis of treatment & diagnosis, the global acute pancreatitis market has been segregated into treatment and diagnosis. The treatment segment is further classified as intravenous fluid, nutritional support, analgesics, endoscopic retrograde cholangiopancreatography (ERCP), and others. The diagnosis segment is further classified as imaging tests and laboratory tests.

On the basis of end-user, the global acute pancreatitis market has been segmented into hospitals & clinics and others.

Regional Analysis

The Global Acute Pancreatitis Market has been segmented based on region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa.

The increasing prevalence of gall stones and alcohol consumption among the population and the availability of advanced healthcare facilities in the US and Canada are likely to support the dominance of the Americas on this market during the forecast period. Additionally, the rising geriatric population increases the rate of prevalence of gallstones as they are more susceptible to diseases. The increasing incidence of acute pancreatitis has led to a rise in the demand for advanced and effective diagnostic tests and treatment options.

Key Findings of the Study:

The Global Acute Pancreatitis Market is projected to reach over USD 7372.01 Million by 2025 at a 91% CAGR during the review period of 2019 to 2025.

Americas accounted for the largest market share with the US being the major contributor to the growth of the market.

By cause, the gallstones segment is projected to register the largest market share of 49.52% during the forecast period. According to a recent research study by the Dutch Pancreatitis Study Group, the most common cause of acute pancreatitis in Europe and North America is gall bladder.  

Key manufacturers are adopting geographic expansions, corporate acquisitions, and product launches as growth strategies.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/acute-pancreatitis-market-1565

Related Reports:

https://healthcaretrendingnews.wordpress.com/2022/01/13/protein-engineering-market-astonishing-growth-with-top-influencing-key-players/

https://healthcaretrendingnews.wordpress.com/2022/01/13/gene-editing-market-2020-global-industry-exhibits-huge-growth-by-top-key-players/

https://healthcaretrendingnews.wordpress.com/2022/01/13/antibody-drug-conjugate-market-in-global-industry-demands-insights-research-and-forecast-2020-2027/

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street,5Th Floor, New York, New York 10013,

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Acute Pancreatitis Market expected to reach USD 7372.01 Million By 2025 at CAGR of 5.91% here

News-ID: 2526265 • Views:

More Releases from Market Research Future (MRFR)

Payment Service Provider Market Projected to Hit USD 140.91 Billion at a 5.48% CAGR by 2034
Payment Service Provider Market Projected to Hit USD 140.91 Billion at a 5.48% C …
Market Overview: The Payment Service Provider (PSP) market has witnessed substantial growth over the past decade, driven by the explosive rise in digital commerce, mobile payments, and cross-border transactions. As businesses strive to streamline payment processes and deliver frictionless experiences to customers, the demand for robust, secure, and scalable PSP solutions has surged. PSPs serve as intermediaries between merchants and financial institutions, enabling the acceptance of electronic payments via multiple methods
Boundary Scan Hardware Market Poised for Growth, Reaching USD 3.16 Billion by 2034
Boundary Scan Hardware Market Poised for Growth, Reaching USD 3.16 Billion by 20 …
Market Overview: The Boundary Scan Hardware Market has emerged as a crucial segment within the electronics testing and debugging industry, offering advanced solutions for fault detection and circuit verification in integrated circuits (ICs) and printed circuit boards (PCBs). Leveraging the IEEE 1149.1 standard, boundary scan commonly referred to as JTAG (Joint Test Action Group) provides a non-invasive and efficient testing methodology that minimizes the need for physical probes. Boundary Scan Hardware
Metaverse for Automotive Market is Expected to Touch USD 123.51 Billion By 2034
Metaverse for Automotive Market is Expected to Touch USD 123.51 Billion By 2034
Market Overview: The Metaverse for Automotive Market is redefining how automakers, suppliers, and consumers interact in a digitally immersive world. With the integration of AR/VR, IoT, blockchain, and AI technologies, the automotive industry is stepping into the virtual realm to enhance everything from product design and manufacturing to marketing, sales, and customer service. The global rise in digital transformation, coupled with increasing consumer demand for interactive and customized experiences, is fueling
AGV Software Market to Grow at 10.82% CAGR, Hitting USD 6.46 Billion by 2034
AGV Software Market to Grow at 10.82% CAGR, Hitting USD 6.46 Billion by 2034
Market Overview: The AGV Software Market is rapidly evolving as industries shift towards intelligent automation and digital transformation in their logistics and material handling operations. AGV software acts as the brain of autonomous vehicles, enabling seamless navigation, scheduling, route optimization, fleet coordination, and task management. With the growing demand for efficient, contactless, and error-free logistics, AGV systems have found significant adoption across warehouses, manufacturing plants, ports, and healthcare facilities. AGV Software

All 5 Releases


More Releases for Acute

Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth